Manner of Production Clause Samples

The "Manner of Production" clause defines the specific methods, standards, or processes that must be followed when producing goods or delivering services under a contract. It typically outlines requirements such as the use of certain materials, adherence to industry standards, or compliance with agreed-upon procedures. For example, it may require that products be manufactured using environmentally friendly techniques or that services be performed according to a particular quality certification. This clause ensures that both parties have a clear understanding of production expectations, reducing the risk of disputes over quality or compliance.
Manner of Production. The certificates representing the Notes shall be typed, printed, lithographed or engraved or produced by any combination of these methods or may be produced in any other manner permitted by the rules of any securities exchange on which the Notes may be listed, all as determined by the Officers of the Issuer executing such Notes, as evidenced by their execution of such Notes.
View SourceView Similar (5)
Manner of Production a) POLYMER shall manufacture, or have manufactured for it pursuant to Section 9 above, all present and future SCJ LICENSED PRODUCTS in accordance with standards approved by SCJ. The quality of all SCJ LICENSED PRODUCTS shall be as approved by SCJ. POLYMER shall send to SCJ for approval a representative specimen of any SCJ LICENSED PRODUCTS as SCJ may request. b) All present and future products manufactured by POLYMER, or to be manufactured for it pursuant to Section 9, and sold under a HOUSE ▇▇▇▇ and/or TRADE NAME in combination with a POLYMER BRAND or a COMBINATION BRAND, shall be of a quality that is consistent with the quality of POLYMER BRAND products as of the date hereof. POLYMER shall send to SCJ representative specimens of any such product or products upon SCJ’s written request.
View Source
Manner of Production. (a) CMI shall manufacture, or have manufactured for it pursuant to Section 10 above, all present and future SCJ LICENSED PRODUCTS in accordance with formulae, processes and procedures and other specifications and standards (such as, for example, [**]) issued or approved by SCJ. The quality of all SCJ LICENSED PRODUCTS and/or of ingredients and raw materials used in all SCJ LICENSED PRODUCTS shall be as specified and approved by SCJ. Upon SCJ’s request, from time to time, CMI shall send to SCJ for written approval a representative specimen of: (i) established SCJ LICENSED PRODUCTS made under a changed formula authorized in writing by SCJ before release for sale; (ii) new SCJ LICENSED PRODUCTS before release for sale; and (iii) any SCJ LICENSED PRODUCTS at such other times as SCJ may request. (b) All present and future products manufactured by CMI, or to be manufactured for it pursuant to Section 10, and sold under a HOUSE ▇▇▇▇ and/or TRADE NAME in combination with a CMI BRAND or a COMBINATION BRAND, shall be of a quality that is consistent with the quality of CMI BRAND and COMBINATION BRAND products, as applicable, as of the date hereof. CMI shall send to SCJ representative specimens of any such product or products upon SCJ’s written request.
View Source
Manner of Production. The Notes shall be typed, printed, lithographed or engraved or produced by any combination of these methods or may be produced in any other manner, all as determined by the Officer executing such Notes, as evidenced by such Officer’s execution of such Notes.
View Source

Related to Manner of Production

  • Marketing of Production Except for contracts listed and in effect on the date hereof on Schedule 7.19, and thereafter either disclosed in writing to the Administrative Agent or included in the most recently delivered Reserve Report (with respect to all of which contracts the Borrower represents that it or its Subsidiaries are receiving a price for all production sold thereunder which is computed substantially in accordance with the terms of the relevant contract and are not having deliveries curtailed substantially below the subject Property’s delivery capacity), no material agreements exist which are not cancelable on 60 days notice or less without penalty or detriment for the sale of production from the Borrower’s or its Subsidiaries’ Hydrocarbons (including, without limitation, calls on or other rights to purchase, production, whether or not the same are currently being exercised) that (a) pertain to the sale of production at a fixed price and (b) have a maturity or expiry date of longer than six (6) months from the date hereof.

  • Conformity of production 8.1. Procedures concerning conformity of production shall comply with those set out in the 1958 Agreement, Schedule 1 (E/ECE/TRANS/505/Rev.3) and meet the following requirements: 8.2. A vehicle approved pursuant to this Regulation shall be so manufactured as to conform to the type approved by meeting the requirements of paragraph 5. above; 8.3. The Type Approval Authority which has granted approval may at any time verify the conformity of control methods applicable to each production unit. The normal frequency of such inspections shall be once every two years.

  • Supply of Product Salix shall use reasonable efforts to supply the Product during the Co-Promotion Period in sufficient quantities to satisfy the levels of Product sales forecasted in the then current Marketing Plan. Salix shall maintain reasonable inventory levels of the Product in order to ensure their ability to fulfill this obligation. Salix shall have the sole responsibility and right to fill orders with respect to the Product. Altana shall not solicit orders for the Product but, if for any reason, Altana shall receive an order for the Product, Altana shall promptly forward to Salix any such orders. All orders for Product shall be subject to acceptance by Salix, in its sole discretion, which acceptance shall not be unreasonably withheld. Salix may cancel any order for Product at any time after acceptance without incurring any liability to Altana. Salix shall be solely responsible for responding to requests from Target Physicians for individual patients who need the Product but are unable to afford it. Any such request shall be forwarded by Altana to Salix for processing. Salix shall have the sole right and responsibility for establishing and modifying the terms and conditions of the sale of the Product, including (a) the price at which the Product will be sold, (b) whether the Product will be subject to trade or quantity discounts, (c) whether any discount will be provided for payments on accounts receivable, (d) whether the Product will be subject to rebates, returns and allowances or retroactive price reductions, (e) the channels of distribution of the Product, and (f) whether credit [*] Confidential treatment requested; certain information omitted and filed separately with the SEC. is to be granted or refused in connection with any sale of Product. In the event that Salix fails to supply the Product as required pursuant to this Agreement for any reason other than a Force Majeure, which such failure results in lost sales for Altana, the Parties shall meet and attempt to negotiate a mutually agreeable and commercially reasonable solution. If the Parties cannot reach such an agreement within a reasonable period of time, the issue will be dealt with as contemplated under Section 4.4 of this Agreement.

  • Supply of Products ‌‌ 3.1 The Supplier warrants that the Products shall: (a) correspond with their description and any applicable Product Specification; (b) conform in all respects with the Order and any relevant sample; (c) be of satisfactory quality and fit for any purpose held out by the Supplier or made known to the Supplier by Ornua, expressly or by implication, and in this respect Ornua relies on the Supplier's skill and judgement; (d) be manufactured by properly trained and qualified personnel using all reasonable skill, care and diligence and in a good and workmanlike manner;‌ (e) where they are manufactured products, be free from defects in design, materials and workmanship and remain so for the period set out in the Product Specification or, if none is specified, for at least 12 months after delivery; (f) comply with all applicable statutory and regulatory requirements relating to the manufacture, labelling, packaging, storage, handling and delivery of the Products;‌ (g) comply with all relevant standards including any UK Standards, European Standards or International Standards applicable in the UK and the country or State where the Products are to be used; and (h) in the case of Products containing food stuffs, when delivered to Ornua, comply with all applicable food and hygiene legislation and regulations and best industry practice.‌ 3.2 The Supplier shall ensure that at all times it has and maintains all licences, permissions, authorisations, consents and permits needed to carry out its obligations under the Contract in respect of the supply of Products. Breach of this Condition shall be deemed a material breach of the Contract. 3.3 Ornua may inspect and test the Products at any time before delivery. The Supplier shall remain fully responsible for the Products despite any such inspection or testing and any such inspection or testing shall not reduce or otherwise affect the Supplier's obligations under the Contract. 3.4 If following such inspection or testing Ornua considers that the Products do not comply or are unlikely to comply with the Supplier's undertakings at clause 3.1, Ornua shall inform the Supplier and the Supplier shall immediately take such remedial action as is necessary to ensure compliance.‌ 3.5 Ornua may conduct further inspections and tests after the Supplier has carried out its remedial actions.

  • Product Labeling The labeling of all Licensed Products sold or offered for sale under this Agreement shall expressly state that the Licensed Product is manufactured under a license from the Medicines Patent Pool.